🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the efficacy and safety of Piemont...
Status
Recruiting
Location
EMS
Start Date
2024-10-08
Trial ID
NCT05028140
Treatments Being Tested
The purpose of this study is to evaluate the effects and safety of pioglita...
Status
Completed
Location
Endocrinology and Metabolism Department, Zhongshan Hospital, Fudan University,
Start Date
2008-03
Trial ID
NCT00633282
Treatments Being Tested
Patients with non-alcoholic fatty liver disease (NAFLD) are at increased ri...
Status
Completed
Location
National Hepatology and Tropical Medicine Research Institute
Start Date
2022-08-01
Trial ID
NCT05254626
Treatments Being Tested
The purpose of this study is to test whether the correction of insulin resi...
Status
Terminated
Location
Hôpital Pitié Salpêtrière, Service d'hépatogastroentérologie
Start Date
2009-12-03
Trial ID
NCT00927290
Treatments Being Tested
A 30-week extension to a 24-week study assessing the hemoglobin A1c (HbA1c)...
Status
Completed
Location
Multiple Locations
Start Date
2007-09-01
Trial ID
NCT01028391
The goal of this study is to test whether monitoring insulin levels and usi...
Status
Recruiting
Location
Rambam Health Care Campus
Start Date
2022-12-25
Trial ID
NCT05753657
Treatments Being Tested
Liver cirrhosis (LC) is the final destiny in chronic liver disease. Liver t...
Status
Completed
Location
Royan Institute
Start Date
2010-06
Trial ID
NCT01454336
Treatments Being Tested
* The present study was undertaken to assess the efficacy and safety of two...
Status
Completed
Location
Bangladesh Institute of Research and Rehabilitation in Diabetes, Endocrine and Metabolic Disorders (BIRDEM)
Start Date
2008-11
Trial ID
NCT01589445
Treatments Being Tested
To study the effects of pioglitazone on the steroidogenic enzyme axis in eu...
Status
Unknown
Location
PGIMER
Start Date
2010-09
Trial ID
NCT01206400
This study will investigate the efficacy and safety of BI 10773 in type 2 d...
Status
Completed
Location
1245.19.10056 Boehringer Ingelheim Investigational Site
Start Date
2010-09
Trial ID
NCT01210001